Fleury S.A. entered into a purchase agreement to acquire Laboratório Marcelo Magalhães S.A. and Marcelo Magalhães Diagnósticos S.A. for an enterprise value of approximately BRL 380 million.

Fleury S.A. (BOVESPA:FLRY3) entered into a purchase agreement to acquire Laboratório Marcelo Magalhães S.A. and Marcelo Magalhães Diagnósticos S.A. for an enterprise value of approximately BRL 380 million on October 18, 2021. It generated gross revenue of BRL 114 million in the last 12 months ended on July 31, 2021. The acquisition requires approval from antitrust body Cade.

Inspire Capital Partners Assessoria Financeira Ltda. acted as the financial advisor to shareholders of Laboratorio Marcelo Magalhaes.